关注
Nattapong Tidwong
Nattapong Tidwong
在 cmu.ac.th 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacological treatment for the Novel Coronavirus disease 2019 (COVID-19 Infection)
N Tidwong, P Montakantikul, W Manosuthi
Pharmaceutical Sciences Asia Review 47 (2), 97-103, 2020
52020
Optimized chloroquine phosphate dosage regimens for early virological clearance of severe acute respiratory syndrome coronavirus 2 using Monte Carlo simulation.
N Tidwong, B Punyawudho, P Leelawattanachai, S Tangtrakultham, ...
Pharmaceutical Sciences Asia 48 (3), 2021
22021
Antibiotic prescribing behavioral assessment of physicians involved in surgical care
K Jantarathaneewat, S Chansirikarnjana, N Tidwong, LM Mundy, ...
Infection Control & Hospital Epidemiology 40 (9), 1079-1081, 2019
22019
Optimized fosfomycin regimens for treating carbapenem‐resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function
N Tidwong, A Chanruang, S Chupradit, SL Parker, P Leelawattanachai, ...
Clinical and Translational Science 17 (10), e70038, 2024
2024
Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019.
K Koyratkoson, N Tidwong, S Tangtrakultham, P Montakantikul
Pharmaceutical Sciences Asia 49 (4), 2022
2022
Optimizing hydroxychloroquine dosing regimen for treatment of pediatric patients with coronavirus disease 2019 using Monte Carlo simulation.
L Treerattanapun, S Tangtrakultham, N Tidwong, P Montakantikul
Pharmaceutical Sciences Asia 49 (1), 2022
2022
Current and Repurposing Medication for SARS-CoV-2 Infection
K Jantarathaneewat, K Kangwantas, N Tidwong
Asian Medical Journal and Alternative Medicine 21, S91-S101, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–7